Viewing Study NCT00613366


Ignite Creation Date: 2025-12-24 @ 4:30 PM
Ignite Modification Date: 2026-02-26 @ 12:20 AM
Study NCT ID: NCT00613366
Status: COMPLETED
Last Update Posted: 2013-03-15
First Post: 2008-01-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Misoprostol With Intrauterine Device Insertion
Sponsor: Oregon Health and Science University
Organization:

Study Overview

Official Title: Effect of Prophylactic Misoprostol Prior to Intrauterine Device Insertion
Status: COMPLETED
Status Verified Date: 2013-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to see if using misoprostol (a medication that softens the cervix) before placing an intrauterine device for contraception reduces pain in women who have never delivered a baby.
Detailed Description: The investigators intend to conduct a randomized double blind study at Oregon Health and Science University and Planned Parenthood of the Columbia Willamette.

Subjects will be approached only after deciding to get an intrauterine. When the participants return for intrauterine device placement, at 90 minutes prior to the procedure half will receive misoprostol and half will receive placebo. The subjects will be asked to rate their level of pain at specific points during the insertion. Providers will be asked to mark whether or not additional dilation was required as well as their perceived ease of intrauterine device placement.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: